Effector cells from the innate immune system are capable of cellular killing, recruitment and priming of adaptive cells. As the role of the tumor microenvironment in the control and elimination of cancer continues to be elucidated, interest has grown in understanding how the innate immune system can be harnessed to increase tumor immune infiltration and improve cancer therapeutics. Measurements of cytokines levels in urinary-based assays have shown the relevance of the bidirectional activation pathway between the innate and adaptive immune systems in patients with bladder cancer, underscoring the key role of innate immunity in priming and directing the antitumor response. PATIENT SUMMARY: Systemic and intravesical immunotherapies are currently available for bladder cancer. However, these agents are effective only in a subset of patients. We consider how integration of scientific breakthroughs on innate immunity may open a new window of potential therapeutic targets that could increase the efficacy of available agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.euf.2020.02.013 | DOI Listing |
BMC Res Notes
January 2025
Department of Anatomy and Neuroscience, Institute of Medicine, University of Tsukuba, 1-1- 1, Tennodai, Tsukuba, Ibaraki, 305-8577, Japan.
Objective: Reactivity of microglia, the resident cells of the brain, underlies innate immune mechanisms (e.g., injury repair), and disruption of microglial reactivity has been shown to facilitate psychiatric disorder dysfunctions.
View Article and Find Full Text PDFCytokine Growth Factor Rev
January 2025
Faculty of Pharmacy, University of Ljubljana, Slovenia. Electronic address:
A cytokine storm is marked by excessive pro-inflammatory cytokine release, and has emerged as a key factor in severe COVID-19 cases - making it a critical therapeutic target. However, its pathophysiology was poorly understood, which hindered effective treatment. SARS-CoV-2 initially disrupts angiotensin signalling, promoting inflammation through ACE-2 downregulation.
View Article and Find Full Text PDFTrends Microbiol
January 2025
Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT7 1NN, UK. Electronic address:
Klebsiella pneumoniae (KP) is a global threat to human health due to the isolation of multidrug-resistant strains. Despite advancements in understanding KP's population structure, antibiotic resistance mechanisms, and transmission patterns, a gap remains in how KP evades defenses, allowing the pathogen to flourish in tissues despite an activated immune system. KP infection biology has been shaped by the notion that the pathogen has evolved to shield from defenses more than actively suppress them.
View Article and Find Full Text PDFThorax
January 2025
Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
Acute respiratory distress syndrome (ARDS) is present in >10% of all people admitted to critical care and is associated with severe morbidity and mortality. Despite more than half a century since its first description, no efficacious pharmacological therapies have been developed, and little progress has been made in improving clinical outcomes. Neutrophils are the principal drivers of ARDS, with their priming and subsequent aberrant downstream functions, including interleukin (IL) 1β and IL-18 secretion, central to the disease pathogenesis.
View Article and Find Full Text PDFJ Allergy Clin Immunol
January 2025
Division of Rhinology, Department of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine; Monell Chemical Senses Center, Philadelphia; PA; Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, PA. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!